1,721,002 research outputs found
Outcomes of using a sutureless bovine pericardial patch graft for Ahmed glaucoma valve implantation
No full textOutcomes of conjunctival compression sutures for hypotony after glaucoma filtering surgery
No full textGinkgo biloba extract improves visual field damage in some patients affected by normal-tension glaucoma
No full textLatanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure
No full text
Response to Letter to the Editor: Glaucoma Surgery During the COVID-19 Pandemic in Italy: How Novel Coronavirus has Changed the Surgical Management of Glaucoma Patients
No full text
The Effect of Phacoemulsification on Intraocular Pressure in Eyes with Hyperfiltration Following Trabeculectomy: A Prospective Study
Full text linkArticle full
text
The full text of this article can be found here.
Provide enhanced digital features for this article
If you are an author of this publication and would like to provide additional
enhanced digital features for your article then please contact [email protected].
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.
Other enhanced features include, but are
not limited to:
• Slide decks
• Videos and animations
• Audio abstracts
• Audio slides</p
Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure
Full text linkTravoprost is a prostaglandin analogue widely used for reducing intraocular pressure (IOP) in patients affected with glaucoma and ocular hypertension. It exerts its ocular hypotensive effect through the prostaglandin FP receptors, located in the ciliary muscle and the trabecular meshwork. Several studies have shown that topical administration of travoprost induces a mean IOP reduction ranging from 25% to 32%, and sustained throughout the 24-hour cycle. When compared with timolol, travoprost is more effective at reducing IOP, while generally no difference has been found in the head-to-head comparison with other prostaglandin analogues. The fixed combination of travoprost and timolol has demonstrated a hypotensive efficacy comparable to the concomitant administration of the two drugs. Recently, a new preservative-free formulation of travoprost 0.004% has been marketed for reducing tolerability-related problems in subjects affected with ocular surface disease. Low rates of topical and systemic adverse reactions, strong ocular hypotensive efficacy, and once-a-day dosing make travoprost a first-line treatment for patients affected with elevated IOP
Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma
No full text- …
